Oncology

As the initial onslaught of the COVID pandemic levels out in some places, hospitals and research organizations are focusing to how to reopen and run clinical trials in the new normal. For the next installment in our series with industry experts discussing how to conduct...

In this installment of our series on how the clinical trials industry is responding to the COVID-19 pandemic, I spoke with Dr. Suzanne Rose, Director of the Office of Research at Stamford Health. Stamford Health consists of Stamford Hospital, Stamford Health Medical Group, Stamford Hospital Foundation, and a diverse...

In this installment of our series on how COVID is affecting clinical trials, I’m speaking with Cedron Williams, director of the office of clinical trials for East Carolina University (ECU) in Greenville, North Carolina. At any given time, ECU’s Brody School of Medicine has between 150 and 200 actively recruiting clinical trials, representing multi-disciplinary collaborations...

May is Cancer Research Month so we asked our Chief Oncologist, Dr. BJ Rimel, and our lead data scientist, Scott Hoch, to shed some light on how Deep 6 is helping advance cancer research through AI-enabled Clinical Trial Acceleration Software.   Deep 6 AI: Why is oncology...